Inflammation Suppresses Patients' Ability to Metabolize Cytochrome P450 Substrate Drugs.
C Michael WhitePublished in: The Annals of pharmacotherapy (2021)
Like other types of drug-drug or drug-disease interactions, inflammation can alter the steady-state concentration of CYP metabolized drugs.